Here’s what the first mRNA flu vaccine could mean for flu season

Moderna’s mFlusiva uses the same technology as COVID-19 vaccines

A white and red box of mFlusiva mRNA flu vaccine from Moderna.

Moderna’s mFlusiva, a flu vaccine approved for use in people age 50 and older, uses the same technology as COVID-19 vaccines.

Moderna

mRNA flu shots have officially arrived.

On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots.